Page 11 - Sanket Koul

Akums Drugs announces JV to set up manufacturing facility in Zambia

Akums will hold 51% in its joint venture with the Zambian government to set up a pharma manufacturing facility, marking its first overseas plant and Africa expansion

15K hospitals to suspend cashless services for Bajaj Allianz policyholders

Hospital body issues notice to Care Health Insurance; says low rates, heavy deductions behind move

CRE Matrix refutes data theft allegations by Delhi-based PropEquity

CRE Matrix denies the allegations of data theft, calling them unfounded, while PropEquity moves the Delhi High Court seeking damages and an injunction

CDSCO flags 8 drugs as spurious, 134 not of standard quality in July

CDSCO flagged eight spurious drugs and 134 substandard formulations in July 2025, while Novo Nordisk reported theft of insulin and Wegovy batches during transit in India

UK businessman Sukhpal Ahluwalia buys Rs 100 cr flat in DLF Camellias

British businessman Sukhpal Ahluwalia has purchased an 11,416 sq ft apartment at DLF's luxury project The Camellias in Gurugram for Rs 100 crore, underscoring demand for high-end homes

Fortis expands UP footprint, signs O&M deal for 550-bed hospital in Lucknow

Fortis Healthcare has partnered with Ekana Group to manage a 550-bed greenfield hospital in Lucknow, expanding its Uttar Pradesh presence alongside its Noida and Greater Noida units

PropEquity sues CRE Matrix for alleged data theft, Delhi HC issues summons

PropEquity has moved the Delhi High Court against CRE Matrix alleging data theft, seeking damages of Rs 8 crore as the court issues summons and sets next hearing for September 19

Landmark Group to invest Rs 400 cr in Gurugram luxury housing project

Landmark Group has announced a Rs 400 crore investment in the second phase of its luxury housing project SKYVUE in Gurugram, featuring premium towers with high-end amenities

Branded homes in high demand; IHCL, Marriott tie up with developers

Hospitality majors like IHCL, Marriott, and others are partnering with developers to tap the growing demand for branded residences, as luxury homebuyers drive the trend across metro and tier-II cities

Govt panel starts drafting rules for refurbished medical device imports

A high-level inter-departmental committee has begun discussions on regulating refurbished medical devices, balancing patient safety concerns with affordable healthcare access

Nathealth calls for GST input slab for healthcare to be capped at 5%

Nathealth urges the government to cap GST input slabs for healthcare at 5% and allow input credits, citing rising embedded taxes that increase costs for providers and patients

Education minister Pradhan introduces IIM Amendment Bill in Lok Sabha

The Bill grants IIM Guwahati a Rs 555 crore fund for five years, making it the second IIM in the Northeast after Shillong, with a permanent campus to come up near Guwahati

Delhi-NCR real estate to gain from UER-II and Dwarka Expressway launch

Real estate developers and consultants say UER-II and the Dwarka Expressway will improve connectivity, ease congestion, and drive housing and commercial growth in Delhi NCR

PM Modi asks scientists to focus on R&D, secure patents for new drugs

PM says move will ensure self-reliance in the pharmaceuticals segment

Anti-rabies vaccine, immunoglobulin sales pick up as dog bite cases jump

Drugmakers aim to step up production by 15-20% in the near term

Realty, hospitality firms upbeat on GST Diwali bonanza and tax relief

Real estate and hospitality companies hope that GST reforms, including lower taxes and simplified compliance, will boost demand, support tourism, and aid in the growth of the economy

NHA, C-DAC launch e-Sushrut@Clinic HMIS for small healthcare providers

NHA and C-DAC have launched e-Sushrut@Clinic, a lightweight, ABDM-enabled HMIS for small and medium healthcare providers to digitise records and offer telemedicine at low cost

Housing micro markets delivering gains for homeowners, investors: Anarock

Delhi NCR's Noida Sector 150 micro market led the pack with a 139 per cent growth in capital values at Rs 13,600 per square feet in Q2 2025 compared to Rs 5,700 per square feet at the end of 2021

Alkem Labs Q1 profit rises 22% to ₹664 cr on India, overseas sales growth

Alkem Labs Q1FY26 profit rose 22% YoY to ₹664.3 crore, with strong growth in India and international sales; company to boost focus on high-potential non-US markets

Zydus Lifesciences Q1 PAT up 5.9% on strong India, int'l formulations biz

The growth was driven by strong performances in the company's domestic and international formulations segments, even as its consumer wellness and US businesses saw muted growth